ANK-700

N/A

Report date: 2024/01/05 17:46:01
NME

Base Information

Drug NameANK-700
Drug Alias NameANK-700
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnokion
China Registration ClassN/A

Develop Information

Active CompaniesAnokionCelgene Corp
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A